NNNYT News🤖Analysis of Alzheimer’s Drugs Stirs Debate About Their EffectivenessThe review said a certain class of drugs had little clinical benefit, but many Alzheimer’s experts criticized the analysis, saying it unfairly lumped failed drugs with two recently approved treatments.By Pam Belluck[1] The New York Times4/16/2026, 3:44:14 AM00000
